Meeting Abstract

THE PROPER STUDY: INTERIM ANALYSIS OF A PAN-EU REAL-WORLD STUDY OF SB5 BIOSIMILAR FOLLOWING TRANSITION FROM REFERENCE ADALIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS, AXIAL SPONDYLOARTHRITIS, OR PSORIATIC ARTHRITIS


AutorenlisteMueller-Ladner, U.; Gaffney, K.; Jadon, D.; Freudensprung, U.; Addison, J.

Jahr der Veröffentlichung2021

Seiten1126-1127

ZeitschriftAnnals of the Rheumatic Diseases

Bandnummer80

ISSN0003-4967

eISSN1468-2060

Open Access StatusBronze

DOI Linkhttps://doi.org/10.1136/annrheumdis-2021-eular.844

KonferenzAnnual European Congress of Rheumatology (EULAR)

VerlagElsevier



Zitierstile

Harvard-ZitierstilMueller-Ladner, U., Gaffney, K., Jadon, D., Freudensprung, U. and Addison, J. (2021) THE PROPER STUDY: INTERIM ANALYSIS OF A PAN-EU REAL-WORLD STUDY OF SB5 BIOSIMILAR FOLLOWING TRANSITION FROM REFERENCE ADALIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS, AXIAL SPONDYLOARTHRITIS, OR PSORIATIC ARTHRITIS, Annals of the Rheumatic Diseases, 80, pp. 1126-1127. https://doi.org/10.1136/annrheumdis-2021-eular.844

APA-ZitierstilMueller-Ladner, U., Gaffney, K., Jadon, D., Freudensprung, U., & Addison, J. (2021). THE PROPER STUDY: INTERIM ANALYSIS OF A PAN-EU REAL-WORLD STUDY OF SB5 BIOSIMILAR FOLLOWING TRANSITION FROM REFERENCE ADALIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS, AXIAL SPONDYLOARTHRITIS, OR PSORIATIC ARTHRITIS. Annals of the Rheumatic Diseases. 80, 1126-1127. https://doi.org/10.1136/annrheumdis-2021-eular.844


Zuletzt aktualisiert 2025-10-06 um 11:30